Future-enable controlled substance ordering to achieve compliance and speed
The DEA is launching its new Controlled Substance Ordering System (CSOS) on December 9, 2024, to facilitate electronic ordering of controlled substances in Schedules I through V. This month, the DEA…
Read the full articleYou might also wanna read
DOJ Announces Controlled Substances Act Scheduling Changes for FDA-Approved Marijuana and State-Licensed Medical Marijuana Products
On April 23, 2026, the U.S. Department of Justice (DOJ), in conjunction with the Drug Enforcement Administration, announced that pursuant to
Adaptive Networks: Why Supply-Side Enforcement Cannot Stop Fentanyl
The Trump administration has made countering fentanyl a core tenet of its national security policy. In January 2025, President Trump signed
FDA Issues Revised Draft Guidance on Demonstrating Substantial Evidence of Effectiveness for Human Drugs and Biological Products
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) unveiled Operation TrialBlazer, a department-wide effort to acceler
DEA Moves to Temporarily Ban Opioid-Like Kratom Compound 7-OH as Schedule I Drug
The federal agency says it will temporarily schedule the drug, which has been called “gas station heroin,” as a controlled substance—a boon
Wired·8d ago
Cresco Labs Obtains DEA Registration for Medical Cannabis Facility
CHICAGO — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis pro
financialpost.com·1mo agoStreamlined and Sponsor-Friendly: What China’s Amended Drug Regulations Mean for Pharma Companies
On January 27, 2026, China’s State Council published the amended Implementing Regulations of the Drug Administration Law, which will take ef
Comments
Sign in to join the conversation.
No comments yet. Be the first.